MedPath

广东罗浮山国药股份有限公司

Ownership
-
Established
2008-12-24
Employees
-
Market Cap
-
Website
https://www.lfsgy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

181

NMPA:181

Drug Approvals

小柴胡颗粒

Approval Number
国药准字Z20044597
Approval Date
Apr 26, 2024
NMPA

罗浮山百草油

Approval Number
国药准字Z44022355
Approval Date
Apr 15, 2024
NMPA

感冒清片

Approval Number
国药准字Z44022333
Approval Date
Apr 15, 2024
NMPA

宫炎平片

Approval Number
国药准字Z20013221
Approval Date
Apr 15, 2024
NMPA

穿心莲片

Approval Number
国药准字Z44020786
Approval Date
Apr 15, 2024
NMPA

消炎利胆片

Approval Number
国药准字Z44021422
Approval Date
Apr 15, 2024
NMPA

降脂宁颗粒

Approval Number
国药准字Z20053248
Approval Date
Apr 15, 2024
NMPA

穿心莲片

Approval Number
国药准字Z20044608
Approval Date
Apr 15, 2024
NMPA

穿心莲片

Approval Number
国药准字Z44021407
Approval Date
Apr 15, 2024
NMPA

喉疾灵片

Approval Number
国药准字Z44023688
Approval Date
Apr 15, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 19
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.